title: QT prolongation induced by hydroxyzine: a pharmacovigilance case report.
authors.affiliation: Department of Pharmacology and Pharmacovigilance, CHU de Caen, Caen, 14032, France.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Vigne
authors.forename: Joachim
authors.initials: J
authors.lastname: Alexandre
authors.forename: Fabienne
authors.initials: F
authors.lastname: Fobe
authors.forename: Paul
authors.initials: P
authors.lastname: Milliez
authors.forename: Magalie
authors.initials: M
authors.lastname: Loilier
authors.forename: Sophie
authors.initials: S
authors.lastname: Fedrizzi
authors.forename: Antoine
authors.initials: A
authors.lastname: Coquerel
mesh_terms: D000368:Aged; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D006919:Hydroxyzine / Q000009:adverse effects*; D008133:Long QT Syndrome / Q000139:chemically induced*; D008297:Male; D060735:Pharmacovigilance
chemical_list: D006634:Histamine H1 Antagonists; D006919:Hydroxyzine